Answers are grounded in this paper and cite their sources.
Transfusion-transmissible infections among 808 blood donors in Ghana were investigated in 1999. Antibody seroprevalences of 3.8, 0.7, 8.4, and 13.5%, respectively, for human immunodeficiency virus, human T-cell lymphotrophic virus type 1, hepatitis C virus (HCV), and Treponema pallidum were obtained. The seroprevalence of HCV infection was confirmed to be 0.9% after supplementary testing, and the transfusion risk potential of these pathogens was demonstrated.
No takes yet. Share an insight, caveat, or question.
Ampofo et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: